The development of reactive oxygen species (ROS)-responsive drug delivery and drug release has gradually attracted much attention in recent years as a promising therapeutic strategy. Singlet oxygen ( 1 O 2 ) as the major ROS species is widely used in photodynamic therapy (PDT) of cancer. In the present study, we introduce a combined treatment using ROS-sensitive thioketal (TK) linkage as a linker between upconversion nanoparticles (UNs)-based PDT and doxorubicin (DOX)-based chemotherapy. UNs can not only play a role in PDT, but can also be used as a nanocarrier for drug delivery of DOX. Moreover, the products of 1 O 2 during PDT are able to cleave TK linker inducing the release of DOX which can further achieve the goal of chemotherapy. By using this 1 O 2 -responsive nanocarrier delivery system, DOX can easily reach the tumor site and be accumulated in the nuclei to effectively kill the cancer cells, and therefore decreasing the side effects of chemotherapy on the body. Thus, PDT also has the function of controlling drug release in this combination treatment strategy. Compared with monotherapy, the combination of PDT with chemotherapy also possesses excellent drug loading capability and anticancer efficiency.
1
O 2 can be generated via resonance energy transfer from UNs to photosensitizer MC540 and cause cellular damage and subsequent cell death. The use of NIR light with the range of wavelengths from 650 to 1350 nm can afford its maximum depth of penetration in tissue, and exhibit an ideal PDT efficiency [1] [2] [3] [4] . A number of studies have shown that the combining PDT with chemotherapy could overcome drug resistance by invoking multiple anticancer mechanisms [5] [6] [7] . DOX is one of the most widely used chemotherapeutic agents in the treatment of a wide range of cancers and is combined with UNs-based PDT in this work. DOX intercalates DNA and inhibits the progression of the enzyme topoisomerase II, thereby inhibits cell growth and reproduction by interferencing DNA replication [8] [9] [10] [11] [12] . UN/MC540 also acted as a nano-sized drug carrier for DOX with high drug concentrations to the targeted cancer cell and reduced toxicity to normal tissue [13] [14] [15] [16] [17] . How to made DOX release and passed through the nuclear pore complex to cause DNA damage was the key of this combined treatment. The thioketal group, which could be readily cleaved by 1 O 2 , was used as the linker between UNs/MC540 and DOX. 1 O 2 , generated by PDT under the excitation of NIR light, was able to trigger the release of doxorubicin from the surface of UN/MC540 in cancer cells [18] [19] [20] . And then DOX molecules more easily reached cell nucleus and led to DNA damage efficiently. Meanwhile, in addition to control drug release, 1 O 2 could also cause cancer cell damage to compensate for the detrimental effects of chemotherapy [21] [22] [23] . Furthermore, UN/ MC540-DOX could be modified by folic acid (FA) to enhance the binding affinity of nanoparticles toward cancer cells 11, [24] [25] [26] . In this work, we developed FA-UN/MC540-DOX as a combination agent for in vivo PDT treatment of tumors (Fig. 1) .
Results
Preparation and Characterization of combination nanoparticles. NaYF4:Yb/Er UNs were synthesized using a modified method reported by literature [27] [28] [29] . The obtained hydrophobic NaYF4:Yb,Er/NaYF4 core/ shell upconversion nanoparticles were converted to hydrophilic ones using an amphiphilic block copolymer, DSPE-PEG (1,2-distearoyl-sn-glycero-3-phosphoethanolamine-polyethylene glycol). The as-synthesized UNs were highly soluble in water [30] [31] [32] [33] [34] . Figure 2a showed a TEM (transmission electron microscopy) image of the hydrophilic UNs and presented uniform structure with an average size of around 25 nm. DLS (dynamic light scattering) analysis exhibited UN/MC540 with a hydrated particle size of 30 nm (Fig. 2b) . UN/MC540-DOX and FA-UN/MC540-DOX were prepared by adding a certain percentage of MC540, DSPE-PEG-DOX and DSPE-PEG-FA in the process of hydrophilic conversion. Their particle size and zeta potential were well maintained in cell culture media by DLS measurements during two weeks (Fig. 2e,f ). The slightly increased particle size and zeta potential indicated the success of the FA anchoring on the membrane surface by comparing these three nanoparticles (Table 1) . Based on the HPLC analysis, the DOX and FA contents in conjugate DSPE-PEG-DOX and DSPE-PEG-FA were calculated to be 16.4 and 13.2 wt%, respectively. And the loading percentage DOX in FA-UN/MC540-DOX was calculated to be 7.2%.
Ability to produce singlet oxygen in solution.
Under 980 nm laser excitation with proper intensity, the emission band at 540 nm was the main emission of upconversion visible fluorescence from UNs, which matched well with the absorption of photosensitizer MC540 (Fig. 2c) (Fig. 3a,b) . ROS-responsive drug release. In addition to kill cancer cells, the generated 1 O 2 in PDT could also control the drug release since DOX was covalently conjugated to UN/MC540 by the 1 O 2 -responsive TK linker 39, 40 . To certify the ability of Improved tumor cell uptake by FA. To achieve efficient accumulation in cancer cells, FA conjugated on the surface of FA-UN/MC540-DOX was used as cancer cell targeting molecule. FA was able to specifically bind to FA receptors over-expressed in a range of tumor cells with a high affinity, enabling FA-UN/MC540-DOX deliver efficiently to cancer cells without causing harm to normal cells 24, [41] [42] [43] . We therefore evaluated the FA effect on cancer cell uptake. As shown in Fig. 5a , FA-UN/MC540-DOX displayed the higher intracellular concentration than UN/MC540-DOX because of the FA modification on the nanoparticle. Similar results were obtained by CLSM imaging. As seen in Fig. 5b , cell nucleus (blue) was stained with Hoechst, cell membrane (red) was labeled with CellMask ™ Deep Red Plasma membrane Stain, and FA-UN/MC540-DOX (green) was detected at 980 nm and corresponding fluorescent images at 540 nm were taken by CLSM 44 . These results together demonstrated that the cellular uptake of FA-UN/MC540-DOX was significantly promoted with the assistance of FA. Nanoparticles internalization played a pivotal role for PDT and chemotherapy. (Fig. 6b) . These results demonstrated the enhanced antitumor activity of FA-UN/MC540-DOX compared with PDT or chemotherapy alone 45 .
In vivo anticancer efficient. DSPE-PEG endowed nanoparticles with stealth behavior to protect them from the RES (reticulo-endothelial system) and easily reached the tumor tissue via EPR effect. Besides, the grafting FA molecules onto the nanoparticles refered to active targeting and aimed to increase specific cancer cells uptake at the tumor site by FA receptor-mediated endocytosis 32, [46] [47] [48] [49] . The injection of Cy5.5-labeled FA-UN/MC540-DOX was more likely to accumulate at the tumor site than non-target nanoparticle in the process of PEG-induced long blood circulation (Fig. 7a) . Having demonstrated the tumor targeting ability of FA, we moved on to explore the antitumor efficacy of different nanoparticles. In comparison with PBS group, all treatment groups showed varying degree of tumor suppression within three weeks. Among them, combination treatment groups exhibited better antitumor effect than free DOX and UN/MC540 group. Notably, targeted modification group showed the greatest anti-cancer effect. Likewise, nuclear apoptosis of cancer cells analysis by TUNEL staining was in agreement with the above results. FA-UN/MC540-DOX induced the greatest cell apoptosis and the tumor was also the smallest, again confirming the success of our combination therapy strategies for cancer cells (Fig. 7b,c) .
Discussion
In conclusion, we have developed an efficient combination control approach for tumor therapy, which consisted of UN-based PDT and chemotherapy. FA-UN/MC540-DOX was applied to an ideal nanoscale drug delivery device with high drug loading for DOX. And the molar percentage of PEG introduced onto the surface of UN/ MC540 endowed the nanocarrier with superior stealth ability to enhance circulation time, and led to tumor accumulation of DOX via EPR effect. Moreover, FR-targeted modification nanoparticle increased cellular uptake and promoted more efficient DOX delivery in vivo. Once FA-UN/MC540-DOX arrived at the tumor site or was uptaken by cancer cells, the produced 1 O 2 in the PDT could quickly trigger the release of DOX from this nanoparticle via cleavage of TK linker. Meanwhile, free DOX was easily able to travel through the nuclear envelope to kill cancer cells efficiently. In addition, UN/MC540-based PDT could also overcome the limitations found in conventional chemotherapy. Thus, our present combination treatment with controlled-release ability exhibits a better anticancer efficacy and paves the way for further research on the clinical application.
Methods
Reagents and materials. LnCl Preparation of UN/MC540-DOX and FA-UN/MC540-DOX. NaYF 4 :Yb,Er (18, 2 mol %) UNs were synthesized as follows: a mixture of YCl 3 (0.8 mmol), YbCl 3 (0.8 mmol) and ErCl 3 (0.02 mmol) dissolved in 2 mL of methanol was mixed in a 50 mL flask. Oleic acid (6 mL) and 1-octadecene (ODE) (15 mL) were added to the above solution, and the mixture was stirred at room temperature for 10 minutes. Methanol solution (5 mL) containing NaOH (2.5 mmol) and NH 4 F (4 mmol) were added into this flask. After that, methanol was evaporated by heating at 100 °C, and the mixture was maintained at 300 °C for 1 h under argon protection. After cooling the reaction mixture to room temperature, medium solution (10 mL) was collected as the core for the later fabrication of core/ shell NaYF 4 :Yb,Er/NaYF 4 UNs. YCl 3 (1 mmol), NaOH (2.5 mmol) and NH 4 F (4 mmol) dissolved in methanol (5 mL) were added into the collected core solution to prepare core/shell UNs. The solution was stirred for 30 min and heated to remove methanol. After being degassed and maintained under argon protection, core/shell UNs were obtained by centrifugation and washed for three times 27 . TK and DSPE-PEG-DOX were synthesized according to the method reported previously (Fig. 8a ) 18, 20 . DOX showed the retention at 8.7 min and DSPE-PEG-DOX showed retention at about 7.1 min with major single peak (Fig. 8b) . To prepare UN/MC540-DOX, 10 mg of DSPE-PEG-DOX and 5 mg of MC540 were added into a 25 mL flask containing 10 mg of UNs and 5 mL of CHCl 3 . This mixture was stirred overnight at room temperature. In this reaction, 5 mg of DSPE-PEG 2000 -Folate was added to prepare targeted modification of PEG-TK-DOX nanoparticles.
Loading percentage of MC540 and DOX in UNs. MC540 and DOX encapsulated within the UNs were determined in triplicate by HPLC with UV detection at 227 nm and 290 nm (LC-20AT, Shimadzu), respectively. The loading percentage was calculated according to the following formula: FA-mediated cellular uptake test. B16 cells were routinely cultured in RMPI 1640 medium with 10% FBS in a humidified incubator with 5% CO 2 at 37 °C. After 24 h, cells were incubated with UN/MC540-DOX and FA-UN/MC540-DOX (10 μ g/mL) at 37 °C for different time intervals. Cells were rinsed with PBS (pH 7.2) solution softly and detached by 0.2% trypsin. And removed typsin by centrifugation at 1000 rpm for 5 min. Cells were then harvested and re-suspended in 100 mL PBS and examined by flow cytometry using a CyAn ADP 9 color flow cytometer (Beckman Coulter). Using the same method, B16 cells were grown in a culture dish at a density of 1 × 10 6 cells/dish and incubated at 37 °C for 24 h. Cells in dishes were incubated with culture containing 200 μ l of the above two kinds of nanoparticles. Then removed medium and washed cells with PBS (pH 7.2). The cell nucleus and cell membrane were stained with Hoechst and CellMask ™ Deep Red Plasma membrane Stain, respectively. FA-UN/MC540-DOX was detected at 980 nm and corresponding fluorescent images at 540 nm was taken by CLSM (TCS SP5, Leica).
Cytotoxicity evaluation. Cytotoxicity of UN nanoparticle was evaluated by CCK-8 kit assay. B16 cells were seeded in 96-well plates at the density of 5 × 10 5 cells/well and cultured for 24 h at 37 °C. Original medium in each well was refreshed with 200 μ L medium containing serial dilutions of UNs (corresponding DOX concentration was 0-10 μ g/mL). After incubation for 48 h, 20 μ L of CCK-8 kit was added to all wells, and then cells were continued to be incubated at 37 °C with 5% CO 2 for 4 h. Infinite M200 microplate spectrophotometer (Tecan, Mannedorf, Switzerland) was used to detect the absorbance at 540 nm. Percent viability was normalized to cell viability in the absence of the samples.
In vivo anticancer efficient. To demonstrate the targeting ability of FA-UN/MC540-DOX in vivo, Cy5.5 dye was loaded into this nanoparticle according to the method described in the preparation of MC540-loaded nanoparticles. B16-bearing mice were injected intravenously with 5 μ g of FA-UN/MC540-DOX and UN/MC540-DOX in 100 μ L of PBS (pH 7.2), respectively. Eight hours after the intravenous administration, mice were anesthetized and scanned using in-vivo imaging system with an excitation at 670 nm and an emission filter at 700 nm.
In the subcutaneous B16 melanoma model, treatments were started when the average tumor volume reached about 100 mm 3 , and mice were randomly divided into five groups. Five groups of eight mice each were intravenously administered PBS (100 μ L, pH 7. PBS group, mice were sacrificed for humane reasons. In other groups, one mouse of each group was sacrificed and tumor tissue was removed for apoptotic analysis. Detection of apoptotic cells by TUNEL (terminal transferase-mediated dUTP nick end labeling) staining accorded to the protocol from Thermo Fisher Scientific.
